Metabolic Syndrome (MetS), a medical condition that is predictive of an increased risk of Type 2 Diabetes Mellitus (T2DM) and cardiovascular disease (CVD), currently affects 47 million U.S. adults. A MetS diagnosis requires that an individual demonstrate three of the following characteristics: central (abdominal) obesity; hypertension (HT); hyperglycemia (HG) and insulin resistance (IR); and dyslipidemia (a low level of HDL cholesterol (HDL-C) and elevated triglycerides).

Three organizations have…

Premium Content
You've reached your monthly limit of free articles.
Access Food Technology
Log in Subscribe